Socrates Health Solutions, Inc. — SEC Form D Filing
Socrates Health Solutions, Inc. filed an SEC Form D on June 2, 2026, reporting $1.50M raised in Health Technology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- June 2, 2026
- Amount reported
- $1.50M
- Round stage
- Seed
- Industry
- Health Technology
- Website
- https://socrateshealthsolutions.com/
What the company does
Securities: Equity, Debt. Revenue: No Revenues. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Managing diabetes effectively requires real-time monitoring and control of blood glucose levels, however current methods often involve invasive procedures like needle insertion or finger pricks.
Solution
Socrates Health Solutions is developing non-invasive blood glucose monitoring devices such as CompanionCM, CompanionSR, and CompanionLS that provide real-time data and eliminate the need for needles and finger pricks.
Why now
There is a growing need for more convenient and less painful solutions for blood glucose monitoring as diabetes prevalence increases.
Verdict
Investors said yes at this moment because the demand for non-invasive diabetes management was creating a significant market opportunity, not because traditional methods were inherently flawed. They were implicitly betting on the growing discomfort with invasive procedures and the broader trend towards user-friendly healthcare solutions. However, the limited upside lies in the potential for competition from both established players and new entrants who could easily replicate the technology, impacting durability.
Source: SEC EDGAR Form D filing